Health Care/Hospital

Presagen's AI Open Projects for clinics enables scalable unbiased AI medical products to be built from globally diverse datasets

SAN MATEO, Calif. and ADELAIDE, Australia, Oct. 30, 2019 /PRNewswire/ -- Presagen has launched a new AI product for clinics at the HLTH conference inLas Vegas, aimed at revolutionizing the way AI is applied to healthcare.   Presagen's AI Open Projects in an online platform that ...

2019-10-30 22:17 413

Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companies

PALO ALTO, California, Oct. 30, 2019 /PRNewswire/ -- Vivo Capital, a healthcare investment firm, announced the final closing of Vivo Capital Fund IX, L.P. (the "Fund") at$1.43 billion in committed capital from a broad group of existing and new global institutional investors. The firm plans to use...

2019-10-30 21:15 390

GC Pharma Reports Q3 2019 Results

YONGIN, South Korea, Oct. 30, 2019 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months endedSeptember 30, 2019. Key Figures Q3 2019(1) Growth(1) Total revenues K...

2019-10-30 21:00 5210

Spectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare Professionals

SMITHS FALLS, Ontario, Oct. 30, 2019 /PRNewswire/ -- Spectrum Therapeutics, the medical division of Canopy Growth Corporation ("Canopy Growth") (TSX:WEED) (NYSE: CGC) is pleased to announce that it has partnered with Tree of Knowledge International Corp. ("Tree of Knowledge") (CSE: TOKI) (OTC: TO...

2019-10-30 20:00 3262

World Pancreatic Cancer Day Campaign Launches to Raise Awareness of the Risks and Symptoms of the World's Toughest Cancer

More than 80 organizations from 30 countries to advocate for early diagnosis of pancreatic cancer onThursday, Nov. 21 MANHATTAN BEACH, California, Oct. 30, 2019 /PRNewswire/ -- Pancreatic cancer has the lowest survival rate among all major cancers because few people know the risks and symptoms a...

2019-10-30 05:47 348

WAT Medical will be returning to 2019 MEDICA to exhibit their innovative wearable technologies

VANCOUVER, British Columbia, Oct. 29, 2019 /PRNewswire/ -- From November 18-21, 2019, WAT Medical will be showcasing their EmeTerm, the anti-vomiting wristband, and HeadaTerm, the anti-migraine head patch, at one of the largest healthcare trade shows, MEDICA, inDusseldorf, Germany at Stand Hall 1...

2019-10-29 21:00 269

Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video

AUSTIN, Texas, Oct. 29, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the confirmation of a further$500,000 non-dilutive funding in the form of a loan from the Texas A&M SOFINEX funding agency of the Walloon Region to support the development of its sub...

2019-10-29 20:30 5299

Herbalife Nutrition Foundation Opens Six New Casa Herbalife Programs in Asia Pacific, Supporting Nutrition Programs for Children in Need

HONG KONG, Oct. 29, 2019 /PRNewswire/ -- Continuing its mission to improve communities around the world, the Herbalife Nutrition Foundation (HNF) has announced the addition of 29 new Casa Herbalife Nutrition programs in 20 countries around the globe. Of the 29 new programs, six are  based in theA...

2019-10-29 15:00 716

Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis

- ADVISE clinical trial initiated and enrollment progressing - Evaluating patients with the clinical diagnosis of moderate-to-severe atopic dermatitis - Significant unmet need for an oral therapy in atopic dermatitis SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ...

2019-10-28 20:30 2564

HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)

SINGAPORE, Oct. 26, 2019 /PRNewswire/ -- HistoIndex announces the expansion of its AI-based digital pathology platform towards large-scale NASH preclinical programs for pharmaceutical and biotech companies to achieve quantifiable and reproducible...

2019-10-26 19:00 506

Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences

SAN FRANCISCO and SUZHOU, China, Oct. 26, 2019 /PRNewswire/ -- Adagene, Inc., a clinical stage biotech company with innovative antibody discovery and engineering technologies, announced that it is presenting its lead program at international conferences.  During the Festival of Biologics confere...

2019-10-26 18:01 583

Wuyi 13th hot Spring Festival and the 10th international health expo opened on 25th

WUYI, China, Oct. 26, 2019 /PRNewswire/ -- A tree that grows old stays green. The news from Fusion media center in Wuyi onOctober 25, the 13th hot Spring Festival and the 10th international health expo opened in Wuyi county. 33 grand activities and thousands of health products attracted nearly 10...

2019-10-26 17:05 461

CHINA AID 2020 Will be Held in Shanghai From 11th-13th June, 2020

SHANGHAI, Oct. 25, 2019 /PRNewswire/ -- CHINA AID 2020 organized by the Shanghai Civil Affairs Bureau, the China Council for the Promotion of International Trade Shanghai and Shanghai Intex Exhibition will be held in Shanghai from 11th-13th June, 2020. As the most established and influential exh...

2019-10-26 00:00 497

Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC

AUSTIN, Texas, Oct. 25, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") announced today that it (through its subsidiaries) has executed binding agreements contemplated by the previously announced Memorandum of Understanding withTexas A&M University ("Texas A&M"), a memb...

2019-10-26 00:00 7816

Happiness Biotech Group Limited Announces Pricing of US$11 Million Firm Commitment Initial Public Offering

NANPING, China, Oct. 25, 2019 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company"), an innovativeChina-based nutraceutical and dietary supplements producer,announced today the pricing of a U.S. underwritten initial public offering ("Offering") of 2,000,000 ordinary shares at a price to...

2019-10-25 22:00 7724

111 to Announce Third Quarter 2019 Unaudited Financial Results on November 14, 2019

SHANGHAI, Oct. 25, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the third quarter endedSeptember 30, 2019, before the open of U.S. ...

2019-10-25 20:00 4419

World first clinical trial commenced in alcohol use disorder

MELBOURNE, Australia, Oct. 24, 2019 /PRNewswire/ -- A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol use disorder, according to researchers at the Florey Institute of Neuroscience and Mental Health. A world-first clinical stu...

2019-10-24 12:01 266

China Jo-Jo Drugstores Hosts Reception of Member of the Standing Committee of Zhejiang Provincial Party Committee and Secretary of Hangzhou Municipal Party Committee of PRC

HANGZHOU, China, Oct. 23, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider in China, today announced tha...

2019-10-23 20:30 4863

HCmed introduces Pulmogine in the 2019 ERS Congress

TAIPEI, Oct. 22, 2019 /PRNewswire/ -- HCmed Innovations Co., Inc., a drug-device combination company focused on inhalation therapy, presented its latest brand, Pulmogine, in the 2019 ERS International Congress. Pulmogine, a mesh nebulizer supported by a customization platform, is able to nebulize...

2019-10-22 16:34 1114

Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health

SHANGHAI, Oct. 22, 2019 /PRNewswire/ -- The implementation of the "Healthy China 2030" Planning Outline has ushered in rapid development of China's big health industry, with the industry scale expected to reachRMB8.78 trillion in 2019 andRMB14.09 trillion in 2023, calculated as per the about 12.5...

2019-10-22 12:08 275
123456 ... 531